Nagendra Boopathy Senguttuvan
Overview
Explore the profile of Nagendra Boopathy Senguttuvan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prashanth A, Kidambi B, Sankaran R, Senguttuvan N, Thangavelu P, Karthikeyan R, et al.
Eur Heart J Imaging Methods Pract
. 2025 Feb;
3(1):qyaf005.
PMID: 39968016
No abstract available.
2.
Senguttuvan N, Subramanian V, Tr M, Sankaranarayanan K, Venkatesan V, Sadagopan T
Indian Heart J
. 2025 Jan;
PMID: 39863253
Cardiovascular disease (CVD) is a major driver of mortality and declining health worldwide. Cardiovascular diseases (CVD) is the most common cause of morbidity and mortality globally. Although dyslipidemia, smoking, diabetes,...
3.
Prashanth A, Kidambi B, Senguttuvan A, Ramalingam V, Sankaran R, Senguttuvan N
Eur Heart J Acute Cardiovasc Care
. 2025 Jan;
14(1):53-54.
PMID: 39749463
No abstract available.
4.
Prashanth A, Kidambi B, Senguttuvan A, Ramalingam V, Sankaran R, Senguttuvan N
Eur Heart J Acute Cardiovasc Care
. 2024 Dec;
14(1):51-52.
PMID: 39724923
No abstract available.
5.
Kumaraguruparan L, Anandaram A, Sambandam K, Chidambaram Y, Kidambi B, Karthikeyan G, et al.
Indian Heart J
. 2024 Sep;
76(5):352-354.
PMID: 39322039
Transfemoral Trans-catheter Aortic Valve Replacement (TF-TAVR) is a safe alternative to surgical aortic valve replacement (SAVR). Protamine is used to reverse heparin and reduce post-TAVR bleeding, but concerns about risks...
6.
Senguttuvan N, Srinivasan N, Panchanatham M, Suliankatchi Abdulkader R, Anandaram A, Polareddy D, et al.
Open Heart
. 2024 Jan;
11(1).
PMID: 38191233
Background: A quarter of patients with severe aortic stenosis (AS) were asymptomatic, and only a third of them survived at the end of 4 years. Only a select subset of...
7.
Senguttuvan N, Bhatt H, Balakrishnan V, Krishnamoorthy P, Goel S, Reddy P, et al.
Front Cardiovasc Med
. 2023 Oct;
10:1282812.
PMID: 37904807
[This corrects the article DOI: 10.3389/fcvm.2023.1130354.].
8.
Ramamurthy M, Balakrishnan V, Vallivedu M, Senguttuvan N, Manokar P, Sankaran R, et al.
Cardiol Cardiovasc Med
. 2023 Aug;
7(2):108-116.
PMID: 37554658
Objectives: To compare the fractional flow reserve (FFR) and diastolic hyperemia-free ratio (DFR) measurements in a population with intermediate coronary artery stenosis and improve the diagnosis. Background: Visual assessment of...
9.
Senguttuvan N, Bhatt H, Balakrishnan V, Krishnamoorthy P, Goel S, Reddy P, et al.
Front Cardiovasc Med
. 2023 Jun;
10:1130354.
PMID: 37351289
Aim: Transfemoral Trans-catheter Aortic Valve Replacement (TF-TAVR) is a safe and effective therapy compared with surgical aortic valve replacement (SAVR) in patients across all risk profiles using balloon-expandable valves (BEV)...
10.
Elkoumy A, Jose J, Gunasekaran S, Kumar A, Srinivas B, Manjunath C, et al.
Int J Cardiol
. 2023 Apr;
382:68-75.
PMID: 37028710
Background: The balloon expandable Myval transcatheter heart valve (THV) showed encouraging results regarding residual aortic regurgitation (AR) from multiple observational studies. The newly designed Myval Octacor has been introduced recently,...